TCF National Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$938K Hold
10,966
0.11% 191
2020
Q4
$1.04M Hold
10,966
0.11% 183
2020
Q3
$954K Sell
10,966
-21
-0.2% -$1.82K 0.11% 187
2020
Q2
$1M Hold
10,987
0.11% 182
2020
Q1
$906K Hold
10,987
0.13% 168
2019
Q4
$1.04M Hold
10,987
0.12% 185
2019
Q3
$954K Buy
+10,987
New +$986K 0.11% 191

Other funds holding NVS

TCF National Bank's NVS Position: Q1 2021 in Review

TCF National Bank held its Novartis (NVS) position steady in Q1 2021 at 10,966 shares worth $938K. The position accounts for 0.11% of the portfolio, ranked #191.

TCF National Bank first reported a position in NVS in Q3 2019 and has held it in 7 quarters since. The position peaked at $1.04M in Q4 2019. 1,135 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

  • TCF National Bank held 10,966 shares of Novartis worth $938K as of Q1 2021.
  • TCF National Bank left its Novartis share count unchanged in Q1 2021.
  • Novartis made up 0.11% of TCF National Bank's portfolio in Q1 2021, its #191 holding.
  • TCF National Bank first reported a position in Novartis in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Novartis position peaked at $1.04M in Q4 2019.
  • 1,135 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.